Merus N.V.

MRUS

Merus N.V.

MRUS

Insider Sentiment (TTM):

Last Purchase:2025-12-29Last Sale:2025-11-26Shares Purchased (TTM):77,203,103Shares Sold (TTM):10,000

Institutional Sentiment:

As of:2025-12-31Institutional Shares Owned:33,412Shares Outstanding:75,675,631Institutional Ownership Pct.:0.04%

Earnings Market Reaction:

Filing Date:2025-10-31Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Assets
Cash And Cash Equivalents At Carrying Value	367	443	197	293	433	629	178	204	242	101	103	148
Marketable Securities Current	268	267	261	244	199	158	159	150	147	164	139	142
Assets Current
Accounts Receivable Net Current	19	17	14	1	1	2	59	2	3	3	5	4
Assets Current	692	768	522	569	666	807	410	369	405	283	258	306
Prepaid Expense And Other Assets Current	37	41	50	31	33	17	14	12	13	15	12	12
Accounts Receivable Related Parties Current	-	-	-	-	-	-	-	-	-	-	-	0
Marketable Securities Noncurrent	181	182	180	187	151	59	61	57	57	47	46	36
Property Plant And Equipment Net	11	11	11	11	12	12	11	12	12	13	13	12
Operating Lease Right Of Use Asset	12	10	9	9	10	10	11	11	11	12	12	13
Intangible Assets Net Including Goodwill	2	2	2	2	2	2	2	2	2	2	2	2
Equity Method Investments	2	2	3	-	-	-	-	-	-	-	-	-
Deferred Income Tax Assets Net	1	1	0	2	1	1	0	1	1	3	2	2
Other Assets Noncurrent	3	4	3	3	3	2	3	3	4	4	4	5
Assets	904	980	731	783	845	892	498	455	492	364	339	377
Liabilities And Stockhold…
Accounts Payable Current	8	21	9	4	6	4	7	5	4	8	5	10
Accrued Liabilities And Other Liabilities	45	41	43	44	36	41	33	38	36	31	40	36
Liabilities Current
Liabilities Current	87	92	89	87	80	81	78	69	64	66	75	79
Taxes Payable Current	7	0	8	7	5	2	2	2	0	1	2	2
Operating Lease Liability Current	3	2	2	2	2	2	2	2	2	2	2	2
Deferred Revenue Current	24	26	28	30	31	32	34	23	23	24	27	29
Operating Lease Liability Noncurrent	10	9	8	8	9	9	10	10	11	11	12	12
Due To Related Parties Current	-	-	-	-	-	-	-	-	-	-	-	0
Deferred Revenue Noncurrent	33	38	38	39	52	55	60	20	24	29	34	39
Liabilities	129	138	135	135	141	145	149	99	99	106	121	129
Due To Related Parties Noncurrent	-	-	-	-	-	-	-	-	-	-	-	0
Common Stock Value	8	8	7	7	7	7	6	6	6	5	5	5
Additional Paid In Capital Common Stock	2,066	2,039	1,686	1,665	1,641	1,616	1,161	1,126	1,118	949	877	871
Stockholders Equity
Stockholders Equity	775	842	596	648	703	747	349	356	393	257	218	247
Accumulated Other Comprehensive Income Loss Net Of…	19	18	-32	-55	-7	-39	-30	-23	-37	-27	-26	-30
Retained Earnings Accumulated Deficit	-1,319	-1,223	-1,065	-968	-937	-838	-788	-753	-693	-670	-638	-598
Liabilities And Stockholders Equity	904	980	731	783	845	892	498	455	492	364	339	377
Common Stock Par Or Stated Value Per Share	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09	0.09
Common Stock Shares Authorized	105	105	105	105	105	105	68	68	68	68	68	68
Common Stock Shares Issued	76	76	69	69	68	68	59	58	58	50	46	46
Shares Outstanding	76	76	69	69	68	68	59	58	58	50	46	46

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2025	42.20%	34.39%	69.46%	-2.39%	2.13%	40.67%	0.95%	2.27%	-	-	-	-
2024	13.06%	25.65%	15.08%	2.23%	-5.25%	0.52%	-8.89%	-16.18%	-20.99%	2.21%	-6.85%	-10.08%
2023	10.15%	36.90%	38.44%	-7.31%	-5.87%	-19.92%	10.03%	23.38%	59.48%	-5.69%	-18.25%	-9.84%
2022	-	-	-	-	-	-	3.99%	-3.99%	-3.60%	2.52%	15.36%	12.95%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Liquidity Ratios
Current Ratio	7.97	8.39	5.86	6.54	8.32	9.97	5.23	5.34	6.29	4.30	3.44	3.88
Quick Ratio	7.55	7.94	5.30	6.18	7.91	9.76	5.05	5.16	6.09	4.07	3.28	3.73
Working Capital	605.13M	676.70M	433.14M	482.00M	586.20M	725.69M	331.77M	299.73M	340.51M	217.28M	183.08M	227.52M
Leverage & Debt
Debt to Equity	0.17	0.16	0.23	0.21	0.20	0.19	0.43	0.28	0.25	0.41	0.56	0.52
Debt Ratio	0.14	0.14	0.18	0.17	0.17	0.16	0.30	0.22	0.20	0.29	0.36	0.34
Efficiency & Turnover
Asset Turnover TTM	0.06	0.06	0.09	0.06	0.05	0.06	0.09	0.11	0.10	0.10	0.11	0.10
Days Sales Outstanding TTM	65.50	60.80	243.18	18.64	23.20	24.26	302.26	26.91	24.22	29.80	31.26	25.23
Receivables Turnover TTM	5.57	6.00	1.50	19.58	15.73	15.05	1.21	13.56	15.07	12.25	11.67	14.47
Per Share Metrics
Diluted EPS TTM	-5.04	-5.42	-4.02	-3.35	-3.58	-2.71	-2.58	-3.00	-3.28	-3.69	-3.28	-2.92
Free Cash Flow Per Share TTM	-4.20	-4.40	-3.47	-2.92	-2.30	-1.69	-2.59	-2.83	-2.64	-3.28	-3.26	-3.51
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Operating Profit Margin TTM	-655.80%	-617.08%	-549.95%	-752.96%	-642.76%	-560.03%	-434.58%	-356.22%	-356.15%	-418.45%	-390.78%	-384.84%
Net Profit Margin TTM	-673.31%	-685.64%	-506.73%	-595.93%	-680.61%	-476.41%	-390.36%	-352.56%	-387.00%	-432.68%	-350.09%	-315.48%
Growth Metrics
Net Revenue Growth (1Y)	57.54%	59.77%	42.77%	-17.78%	-21.33%	-14.63%	-11.73%	5.68%	185.02%	78.35%	90.42%	113.23%
Net Income Growth (1Y)	55.85%	129.94%	85.32%	38.97%	38.36%	-6.00%	-1.57%	18.10%	177.73%	231.03%	101.23%	96.35%
EPS Growth (1Y)	40.56%	100.04%	55.97%	11.67%	9.20%	-26.56%	-21.50%	2.80%	137.45%	198.93%	88.92%	68.90%
Calculated Values
Free Cash Flow TTM	-317.87M	-313.16M	-239.68M	-187.50M	-157.20M	-104.24M	-150.33M	-146.24M	-142.44M	-158.45M	-151.11M	-157.49M
Net Debt	-367.49M	-443.53M	-197.90M	-294.03M	-433.00M	-630.23M	-178.17M	-204.25M	-242.62M	-101.86M	-102.64M	-148.44M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-12-29Purchase

Owner: Genmab, A/S

Title: -

Shares: 76,920,005

Price/Share: $97.00

Value: $7,461,240,485.00

Shares Owned: 73,884,293

Relationship: TenPercentOwner

Ownership: Indirect

2025-12-24Purchase

Owner: Genmab, A/S

Title: -

Shares: 96,082

Price/Share: $97.00

Value: $9,319,954.00

Shares Owned: 72,685,899

Relationship: TenPercentOwner

Ownership: Indirect

2025-12-19Purchase

Owner: Genmab, A/S

Title: -

Shares: 66,264

Price/Share: $97.00

Value: $6,427,608.00

Shares Owned: 72,013,065

Relationship: TenPercentOwner

Ownership: Indirect

2025-12-16Purchase

Owner: Genmab, A/S

Title: -

Shares: 120,752

Price/Share: $97.00

Value: $11,712,944.00

Shares Owned: 71,583,829

Relationship: TenPercentOwner

Ownership: Indirect

2025-11-26Sale

Owner: Shuman, Harry

Title: VP Controller, PAO

Shares: 1,700

Price/Share: $96.10

Value: $163,370.00

Shares Owned: 11,002

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-12-29	Genmab, A/S	TenPercentOwner	-	Indirect	Purchase	76,920,005	97.00	$7,461,240,485.00	73,884,293	4
2025-12-24	Genmab, A/S	TenPercentOwner	-	Indirect	Purchase	96,082	97.00	$9,319,954.00	72,685,899	4
2025-12-19	Genmab, A/S	TenPercentOwner	-	Indirect	Purchase	66,264	97.00	$6,427,608.00	72,013,065	4
2025-12-16	Genmab, A/S	TenPercentOwner	-	Indirect	Purchase	120,752	97.00	$11,712,944.00	71,583,829	4
2025-11-26	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	1,700	96.10	$163,370.00	11,002	4
2025-11-25	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	8,300	95.92	$796,136.00	11,002	4
2025-07-17	Silverman, Peter B.	Officer	COO & GC	Direct	Sale	25,000	60.00	$1,500,000.00	0	4
2025-07-10	Silverman, Peter B.	Officer	COO & GC	Direct	Sale	16,805	55.00	$924,275.00	0	4
2025-06-20	Silverman, Peter B.	Officer	COO & GC	Direct	Sale	34,000	52.76	$1,793,840.00	0	4
2025-03-21	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	4,000	48.52	$194,080.00	11,002	4
2024-08-21	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	2,500	54.00	$135,000.00	7,002	4
2024-06-27	Silverman, Peter B.	Officer	COO & GC	Direct	Sale	10,000	60.00	$600,000.00	0	4
2024-06-17	Silverman, Peter B.	Officer	COO & GC	Direct	Sale	62,000	56.52	$3,504,240.00	0	4
2024-06-12	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	7,300	57.84	$422,232.00	7,002	4
2024-06-04	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	6,000	52.98	$317,880.00	7,002	4
2023-12-19	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	115	26.68	$3,068.20	7,002	4
2023-12-15	Silverman, Peter B.	Officer	COO & GC	Direct	Sale	22,386	25.00	$559,650.00	0	4
2023-12-08	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	250	24.44	$6,110.00	7,117	4
2023-12-01	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	575	24.58	$14,133.50	7,367	4
2023-06-01	Shuman, Harry	Officer	VP Controller, PAO	Direct	Sale	575	21.48	$12,351.00	5,442	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2025-12-31

0.04%

Inst. Shares: 33,412

Shares Outstanding: 75,675,631

2025-09-30

86.23%

Inst. Shares: 65,256,043

Shares Outstanding: 75,675,631

2025-06-30

100.69%

Inst. Shares: 71,585,240

Shares Outstanding: 71,096,937

2025-03-31

99.40%

Inst. Shares: 68,603,594

Shares Outstanding: 69,017,576

2024-12-31

105.61%

Inst. Shares: 67,824,247

Shares Outstanding: 64,220,765

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2025-12-31	33,412	75,675,631	0.04%
2025-09-30	65,256,043	75,675,631	86.23%
2025-06-30	71,585,240	71,096,937	100.69%
2025-03-31	68,603,594	69,017,576	99.40%
2024-12-31	67,824,247	64,220,765	105.61%
2024-09-30	65,564,905	68,254,120	96.06%
2024-06-30	63,694,058	61,851,260	102.98%
2024-03-31	48,916,021	58,085,416	84.21%
2023-12-31	50,898,776	51,605,444	98.63%
2023-09-30	47,146,534	53,869,762	87.52%
2023-06-30	38,979,883	48,321,708	80.67%
2023-03-31	34,312,977	46,323,772	74.07%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Merus N.V. (MRUS) — SEC Financial Statements & Analysis

Merus N.V. (MRUS) is a pharmaceutical preparations company, incorporated in P7. Merus N.V. trades on Nasdaq as: MRUS. Based on its latest SEC filing (Form 10-Q, period ending 2025-09-30), Merus N.V. reported a 57.54% year-over-year revenue growth, a Debt-to-Equity ratio of 0.17x. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 57.54%
Debt To Equity: 0.17x

Data as of 2025-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Merus N.V. in?

Merus N.V. (MRUS) operates in the Pharmaceutical Preparations industry.

What exchange does MRUS trade on?

Merus N.V. (MRUS) trades on the Nasdaq.

Where is Merus N.V. incorporated?

Merus N.V. is incorporated in Netherlands.

Merus N.V.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Merus N.V. (MRUS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.
Main Street's price.

Merus N.V. (MRUS) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Pharmaceutical Preparations

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.